Categories: AnalystsCleantech

M Partners analyst John Safrance cuts target on 5N Plus

The headquarters of St. Laurent, Quebec’s 5N Plus. M Partners analyst John Safrance says the company’s most recent quarter underscores the volatile nature of its business, which he says is driven by the sometimes rapid changes to underlying commodity prices. On Tuesday, 5N Plus (TSX:VNP) reported its Q2, 2012 results. Revenue increased by 15% to $140.1-million compared to the $122-million the company posted in the same period last year. The bottom line news wasn’t as good though, as the company lost $21.9-million or $.29 cents a share versus last year’s net earnings of $8.5-million or $.14 cents a share.

5N Plus CEO Jacques L’Ecuyer said: “We saw relatively strong demand for most of our products during the quarter which enabled us to continue reducing working capital and debt levels through significant cash flow generation.” However, added L’Ecuyer: “…the quarter was characterized by sharp decreases in the prices of almost all of our underlying commodities, especially in the back-end of the quarter, which led to decreases in average selling prices and further impairment charges on our inventories at the end of the quarter.”

M Partners analyst John Safrance says the numbers from 5N Plus were disappointing. He says the quarter underscores the volatile nature of 5N Plus’s business, which he says is driven by the sometimes rapid changes to underlying commodity prices. In a research update to clients today, Safrance maintained his BUY recommendation on 5N Plus, but lowered his target to $2.65 from his previous target of $5.75.

_______________________________

This story is brought to you by Cantech Letter sponsor BIOX (TSX:BX). The largest producer of biodiesel in Canada, BIOX’s proprietary production process has the capability to use a variety of feedstock, including recycled vegetable oils, agricultural seed oils, yellow greases and tallow. For more information CLICK HERE.

________________________________

St. Laurent, Quebec’s 5N Plus, which derives its name from the purity of its products, 99.999% (five nines) took off when the company, which produces essential components of thin-film solar modules, became a primary material supplier to US cleantech giant First Solar. When First Solar’s revenue was skyrocketing, it was being supplied cadmium telluride cells by 5N Plus.

5N Plus, meanwhile, was mirroring First Solar’s action, albeit on a much smaller scale. Sales increased from $10.3 million for the fiscal year ended May 31, 2005 to over $181 million in fiscal 2011. That moved shares of the company from a 2008 low of $3.50 to a high of $9.85 in March of last year, but since that time the stock’s price has fallen below its 2008 levels.

5N Plus’ topline has been helped by last April’s acquisition of Belgium’s MCP Group, which was one of the world’s leading producers of specialty metals such as bismuth, gallium, indium, selenium and tellurium. The acquisition, which cost just over $315 million, dramatically increased 5N’s scale, but the company is clearly having trouble digesting the pickup amid the current tumult in the solar business. Management said adding MCP exposed it to greater seasonality.

Safrance says he expects 5N Plus will generate approximately $5 million in EBITDA per quarter solely from sales to First Solar. However, he says, this most recent quarter did not qualify as a reworked supply contract supplanted a previous arrangement. The M Partners analyst says he expects things will normalize by the fourth quarter of this year.

Shares of 5N Plus closed today down 4.2% to $1.82.

_________________________________

__________________________________

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: vnp
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

14 hours ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

15 hours ago

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

2 days ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

2 days ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

2 days ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

4 days ago